Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|May 9, 2012
Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodiesYu Zhou, Anne-Laure Goenaga, Brian D Harms, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 30, 2012
Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screensJiping Zhang, Matthildi Valianou, Heidi Simmons, et al.
Molecular Imaging and Biology|February 19, 2017
Molecular Simulation of Receptor Occupancy and Tumor Penetration of an Antibody and Smaller Scaffolds: Application to Molecular ImagingKelly D Orcutt, Gregory P Adams, Anna M Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Effective treatment of established human breast tumor xenografts in immunodeficient mice with a single dose of the alpha-emitting radioisotope astatine-211 conjugated to anti-HER2/neu diabodiesMatthew K Robinson, Calvin Shaller, Kayhan Garmestani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2019
CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic MalignanciesAlba Rodriguez-Garcia, Prannda Sharma, Mathilde Poussin, et al.
Cancer Research|September 3, 2004
A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient miceGregory P Adams, Calvin C Shaller, Ekaterina Dadachova, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 10, 2006
Isolation of scFvs to in vitro produced extracellular domains of EGFR family membersEva Horak, Tara Heitner, Matthew K Robinson, et al.
ACS Nano|October 20, 2022
Ultrasmall Folate Receptor Alpha Targeted Enzymatically Cleavable Silica Nanoparticle Drug Conjugates Augment Penetration and Therapeutic Efficacy in Models of CancerFei Wu, Pei-Ming Chen, Thomas C Gardinier, et al.
Plos Pathogens|November 8, 2008
Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathwayJianhua Sui, Daniel R Aird, Azaibi Tamin, et al.
Molecular Cancer Therapeutics|January 1, 2016
Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian CancerAndrea M Patterson, Saghar Kaabinejadian, Curtis P McMurtrey, et al.
Pageof 5